Close Menu

malaria

Examining more than half of its genome, researchers found the parasite's success is due to stripping its genome down to essential genes.

In Science this week: malaria resistance variants, and more.

Copy number alterations in red blood cell invasion receptor-related genes that are more common in some African populations appear to protect against severe malaria.

In Genome Biology this week: Mycobacterium tuberculosis population dynamics, mapping precision in GWAS, and more.

In PLOS this week: blood pressure and hypertension loci in people of African ancestry, Plasmodium vivax population genomics, and more.

In PNAS this week: genetic feature of ALL relapse in Down syndrome patients, Plasmodium falciparum parasite strain structure, and more.

P. falciparum by Dr. Osaro Erhabor, Wikimedia Commons

The studies provide further support for Meridian's Illumigene Malaria as a tool for routine screening of travelers in non-endemic areas of the world.

The selective whole-genome amplification approach was successfully adapted to Plasmodium vivax, a parasite that is notoriously difficult to culture.

In PLOS this week: gut microbial communities of Kenyan children, transcriptional patterns in model of visceral leishmaniasis infection, and more.

The effectiveness of gene drives will likely be dampened by evolution, Nature News reports.

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.